Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Harada

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Cancer Immunology, Immunotherapy : CII|June 23, 2021
T-cell responses and combined immunotherapy against human carbonic anhydrase 9-expressing mouse renal cell carcinomaMamoru Harada, Yuichi Iida, Hitoshi Kotani, et al.
International Journal of Oncology|March 11, 2004
HER2/neu-derived peptides recognized by both cellular and humoral immune systems in HLA-A2+ cancer patientsYuki Ishihara, Mamoru Harada, Koichi Azuma, et al.
Oncology Reports|April 6, 2006
In vivo growth of transitional and renal cell carcinoma cell lines can be suppressed by the adenovirus-mediated expression of a soluble form of vascular endothelial growth factor receptorHaruhiko Ichikura, Masatoshi Eto, Hikaru Ueno, et al.
Molecular Cancer Therapeutics|December 1, 2019
Anticancer Activity of ZnO Nanoparticles against Human Small-Cell Lung Cancer in an Orthotopic Mouse ModelRyosuke Tanino, Yoshihiro Amano, Xuexia Tong, et al.
The Journal of Urology|February 14, 2007
Identification of target antigens in specific immunotherapy for renal cell carcinomaYoshihiro Komohara, Mamoru Harada, Yoshimi Arima, et al.
Breast Cancer Research and Treatment|December 29, 2011
Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancerTouko Inao, Nanae Harashima, Hiroyuki Monma, et al.
Journal for Immunotherapy of Cancer|July 18, 2020
Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cellsYuichi Iida, Rintaro Yoshikawa, Akihiko Murata, et al.
Cancer Science|August 22, 2009
Delayed growth of EL4 lymphoma in SR-A-deficient mice is due to upregulation of nitric oxide and interferon-gamma production by tumor-associated macrophagesYoshihiro Komohara, Kenichi Takemura, Xiao Feng Lei, et al.
Cancer Science|June 29, 2019
Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicityTouko Inao, Hitoshi Kotani, Yuichi Iida, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2005
A unique gene having homology with the kinesin family member 18A encodes a tumour-associated antigen recognised by cytotoxic T lymphocytes from HLA-A2+ colon cancer patientsShigeki Shichijo, Masaaki Ito, Kouichi Azuma, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Cancer Immunology, Immunotherapy : CII|June 23, 2021
T-cell responses and combined immunotherapy against human carbonic anhydrase 9-expressing mouse renal cell carcinomaMamoru Harada, Yuichi Iida, Hitoshi Kotani, et al.
International Journal of Oncology|March 11, 2004
HER2/neu-derived peptides recognized by both cellular and humoral immune systems in HLA-A2+ cancer patientsYuki Ishihara, Mamoru Harada, Koichi Azuma, et al.
Oncology Reports|April 6, 2006
In vivo growth of transitional and renal cell carcinoma cell lines can be suppressed by the adenovirus-mediated expression of a soluble form of vascular endothelial growth factor receptorHaruhiko Ichikura, Masatoshi Eto, Hikaru Ueno, et al.
Molecular Cancer Therapeutics|December 1, 2019
Anticancer Activity of ZnO Nanoparticles against Human Small-Cell Lung Cancer in an Orthotopic Mouse ModelRyosuke Tanino, Yoshihiro Amano, Xuexia Tong, et al.
The Journal of Urology|February 14, 2007
Identification of target antigens in specific immunotherapy for renal cell carcinomaYoshihiro Komohara, Mamoru Harada, Yoshimi Arima, et al.
Breast Cancer Research and Treatment|December 29, 2011
Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancerTouko Inao, Nanae Harashima, Hiroyuki Monma, et al.
Journal for Immunotherapy of Cancer|July 18, 2020
Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cellsYuichi Iida, Rintaro Yoshikawa, Akihiko Murata, et al.
Cancer Science|August 22, 2009
Delayed growth of EL4 lymphoma in SR-A-deficient mice is due to upregulation of nitric oxide and interferon-gamma production by tumor-associated macrophagesYoshihiro Komohara, Kenichi Takemura, Xiao Feng Lei, et al.
Cancer Science|June 29, 2019
Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicityTouko Inao, Hitoshi Kotani, Yuichi Iida, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2005
A unique gene having homology with the kinesin family member 18A encodes a tumour-associated antigen recognised by cytotoxic T lymphocytes from HLA-A2+ colon cancer patientsShigeki Shichijo, Masaaki Ito, Kouichi Azuma, et al.
Pageof 11